Designation supports accelerated development of AI-driven platform to improve outcomes and reduce clinical burden. DETROIT and OR YEHUDA, Israel, Sept. 16, 2025 /PRNewswire/ — PatenSee, a clinical-stage medical device company, announced that the U.S. Food and Drug Administration (FDA)…